Pathologically stiff erythrocytes impede contraction of blood clots: Reply to comment
Valerie Tutwiler(Rutgers, The State University of New Jersey), John W. Weisel(University of Pennsylvania), Vladimir R. Muzykantov(Translational Therapeutics (United States)), Anna D. Protopopova(University of Pennsylvania), David R. Myers(The Wallace H. Coulter Department of Biomedical Engineering), Chandrasekaran Nagaswami(University of Pennsylvania), Carlos H. Villa(Center for Biologics Evaluation and Research), Osheiza Abdulmalik(Children's Hospital of Philadelphia), Wilbur A. Lam(Georgia Institute of Technology), Eric Woods(Max-Planck-Institut für Nachhaltige Materialien), Rustem I. Litvinov(University of Pennsylvania), Janice Russell(Children's Hospital of Philadelphia), Don L. Siegel(University of Pennsylvania)
Cited by 0
Related Papers
Control of Endothelial Targeting and Intracellular Delivery of Therapeutic Enzymes by Modulating the Size and Shape of ICAM-1-targeted Carriers
|Molecular Therapy|2008|566
In vivo hematopoietic stem cell modification by mRNA delivery
|Science|2023|321
Computational Design of Peptides That Target Transmembrane Helices
|Science|2007|293
Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
|Molecular Therapy|2021|272
5‐hydroxymethyl‐2‐furfural modifies intracellular sickle haemoglobin and inhibits sickling of red blood cells<sup>†,‡</sup>
|British Journal of Haematology|2005|244